Composition
- Active ingredients
- CYCLOPHOSPHAMIDE 100MG/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CYCLOPHOSPHAMIDE 2GM/VIAL · InjectableANDA040015-005 · Discontinued
- CYCLOPHOSPHAMIDE 500MG/VIAL · InjectableANDA040015-003 · Discontinued
- CYCLOPHOSPHAMIDE 100MG/VIAL · InjectableANDA040015-001 · Discontinued
- CYCLOPHOSPHAMIDE 1GM/VIAL · InjectableANDA040015-004 · Discontinued
- CYCLOPHOSPHAMIDE 200MG/VIAL · InjectableANDA040015-002 · Discontinued
- CYCLOPHOSPHAMIDE 2GM/VIAL · InjectableANDA087442-005 · Discontinued
- CYCLOPHOSPHAMIDE 500MG/VIAL · InjectableANDA087442-003 · Discontinued
- CYCLOPHOSPHAMIDE 100MG/VIAL · InjectableThis page
- CYCLOPHOSPHAMIDE 1GM/VIAL · InjectableANDA087442-004 · Discontinued
- CYCLOPHOSPHAMIDE 200MG/VIAL · InjectableANDA087442-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA087442.
At a glance
- Brand name
- Neosar
- Active substance
- cyclophosphamide
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Bedford
- Status
- Discontinued
- FDA approval
- 16 Feb 1982
- Application
- ANDA087442-001



